Table 3:
Analytical results at admission.
| Total n=197 | Mild n=127 | Critical n=70 | p-Value | |
|---|---|---|---|---|
| Analytical parameters (median, IQR) | ||||
| Leukocytes, ×109/L | 6.76 (4.78–9.10) | 6.15 (4.30–7.84) | 8.74 (6.14–11.93) | <0.001 |
| Lymphocytes, ×109/L | 0.96 (0.75–1.34) | 1.01 (0.77–1.31) | 0.91 (0.63–1.44) | 0.320 |
| Neutrophils, ×109/L | 5.35 (3.15–7.48) | 4.49 (2.79–6.25) | 7.23 (4.34–10.67) | <0.001 |
| Hemoglobin, g/L | 131 (119–144) | 133 (121–146) | 126 (115–137) | 0.004 |
| Platelets, ×109/L | 203 (158–271) | 201 (157–269) | 209 (160–275) | 0.496 |
| ESR, mm/h | 47 (16–70) | 36 (15–64) | 56 (19–84) | 0.024 |
| PT, s | 12.0 (11.4–13.0) | 11.9 (11.4–12.6) | 12.6 (11.8–13.7) | 0.002 |
| APTT, s | 32.1 (28.8–37.0) | 31.4 (28.5–36.0) | 33.4 (29.8–38.2) | 0.047 |
| d-dimer, mg/L | 0.91 (0.54–1.92) | 0.80 (0.47–1.38) | 1.54 (0.71–3.42) | <0.001 |
| Creatinine, µmol/L | 83.1 (63.6–115.8) | 76.9 (63.6–104.3) | 107.9 (72.5–136.1) | 0.001 |
| Total bilirubin, µmol/dL | 6.8 (5.1–10.3) | 6.8 (5.1–10.3) | 7.7 (5.1–12.5) | 0.009 |
| ALT, U/L | 23.0 (14.0–34.4) | 23.0 (14.1–34.0) | 23.0 (13.6–37.0) | 0.968 |
| AST, U/L | 33 (23–50) | 31 (23–46) | 36 (23–54) | 0.331 |
| GGT, U/L | 39 (23–86) | 31 (21–67) | 54 (29–125) | 0.002 |
| LDH, U/L | 294 (238–411) | 288 (234–365) | 322 (242–538) | 0.023 |
| CRP, mg/L | 69.3 (24.4–140.8) | 51.3 (17.9–120.5) | 117.6 (50.2–247.8) | <0.001 |
| PCT, ng/mL | 0.12 (0.08–0.29) | 0.09 (0.06–0.14) | 0.31 (0.16–0.73) | <0.001 |
| Ferritin, µg/L | 507 (244–1,052) | 462 (224–781) | 677 (276–1,335) | 0.012 |
ESR, erythrocyte sedimentation rate; PT, prothrombin time; APTT, activated partial thromboplastin time; ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, γ-glutamyltransferase; LDH, lactate dehydrogenase; CRP, C-reactive protein; PCT, procalcitonin.